domenica, 3 maggio 2026

Notizie AIOM – anno XV

3 Novembre 2017

Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study

To date, the burden of cancer among young adults has rarely been studied in depth. Our aim was to describe the scale and profile of cancer incidence and mortality worldwide among 20–39 year-olds, highlighting major patterns by age, sex, development level, and geographical ...
Leggi tutto

3 Novembre 2017

FDA Approves New Treatment for Adults With Mantle Cell Lymphoma

October 31, 2017 - The U.S. Food and Drug Administration (FDA) today granted accelerated approval to acalabrutinib for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. “Mantle cell lymphoma is a particularly aggressive ...
Leggi tutto

3 Novembre 2017

FDA Approval Sought for Frontline Brentuximab Vedotin for Hodgkin Lymphoma

November 2, 2017 - A supplemental new drug application has been submitted for brentuximab vedotin in combination with Adriamycin, vinblastine, dacarbazine (AVD) as a frontline treatment for advanced classical Hodgkin lymphoma, according to a statement from the company developing ...
Leggi tutto

3 Novembre 2017

NICE Recommends Frontline Atezolizumab for Advanced Urothelial Cancer

November 1, 2017 - The UK’s National Institute for Health and Care Excellence (NICE) is recommending the use of atezolizumab for treatment-naïve patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-based therapy. ...
Leggi tutto

3 Novembre 2017

Web-app

Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul tumore del pancreas è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, ...
Leggi tutto

3 Novembre 2017

Effect of Comorbidity on Prostate Cancer–Specific Mortality: A Prospective Observational Study

To determine the effect of comorbidity on prostate cancer (PCa)-specific mortality across treatment types. These are the results of a population-based observational study in Sweden from 1998 to 2012 of 118,543 men who were diagnosed with PCa with a median follow-up of 8.3 ...
Leggi tutto

3 Novembre 2017

30 ottobre 2017 – Da Agenzie UE indicatori utili per misurare l’antimicrobico-resistenza

3 Novembre 2017

2 novembre 2017 – Sunset Clause – Elenco delle AIC decadute per mancata commercializzazione

3 Novembre 2017

3 novembre 2017 – Comunicazione EMA sui farmaci contenenti flupirtina

30 Ottobre 2017

27 ottobre 2017 – Comunicazione EMA su farmaci contenenti flupirtina